About US
Contact us
-
Warp Speed initiative aims for COVID-19 vaccine production within 6 weeks: ReutersThe U.S. governmenthas dumped billionsinto COVID-19 vaccine developmentand manufacturing as part of its Warp Speed initiative. Now, withvaccine makers moving rapidlytoward approval, the administratio2020/7/14
-
Amgen doubles down on BeiGene investment as Chinese biotech aims to raise $2.1BIn an eye-catching transpacific collaboration last year, Amgen poured out $2.7 billion to tap into BeiGene’s commercial and R&D expertise in China. But what if an additional equity raise diluted2020/7/13
-
Roche's Tecentriq-Avastin pairing fails to keep ovarian cancer at bayImmune checkpoint inhibitors have gained a foothold in several tumor types, but not so much in ovarian cancer. Now, an early attempt by Roche to change that situation has failed. Adding PD-L1 inhibit2020/7/13
-
Moderna inks fill-finish pact with Spain's Rovi for 'hundreds of millions' of COVID-19 shot dosesModerna is on a steady marchto market with its mRNA-based COVID-19 vaccine, and the company is snapping up manufacturing capacity along the way. After inking onefill-finish deal with major CDMO Catal2020/7/10
-
FDA blasts India's Vega Life Sciences over deleted data from faulty solvent testingThe laundry list of potential faults during an FDA inspection runs long, but brazen errorstend to get investigators especially riled up. That was certainly the case with Indian drugmaker Vega Life Sc2020/7/10
-
Mylan recalls lot of injectable daptomycin after particulates show up in vialOn the heels of a carcinogen scare that drove the company to pull three lots of a short-term ulcer treatment in January, Mylan has issued another recall, this time over particles found in a sample vi2020/7/9
-
Could Amgen test Enbrel or other anti-TNF drugs against COVID-19? CEO Bradway drops a hintAs Amgen ramps up a clinical trial of its psoriasis drug Otezla in COVID-19, the company’s scientists may be seriously considering whether another of its blockbuster anti-inflammatories, Enbrel, coul2020/7/9
-
AstraZeneca, Lilly, Sanofi and others raise prices to start July: reportA pandemic hasn’t stopped some pharma companies from implementing their traditional mid-year price hikes. AstraZeneca, for instance, raised prices on 21 medicines from 1.5% to 6% this month, GoodRxr2020/7/8
-
Lupin pulls diabetes drug metformin off shelves as carcinogen worries continue to buildDiabetes med metformin has been in the FDA's crosshairs since the agency found high levels of a probable carcinogen, NDMA, that had already triggered global recalls for Zantac and a commonly used cla2020/7/8
-
With COVID-19 vaccines coming, SiO2 injects $163M into vial production plantAs COVID-19 vaccines move into late-stage testing, governments and drugmakers are scrambling to secure packaging to store those shots. One Alabama-based materials manufacturerhopes to ease that strai2020/7/7